Lugano Classification became the main response criteria in 2014 for lymphoma, which is one of the most common hematologic malignancies. Lymphoma accounts for approximately 4% of cancer diagnoses in the US. Lymphoma is a cancer of lymphocyte (immune cells) and typically involves nodes, spleen, liver,...
The Response Assessment in Neuro-Oncology (RANO) criteria have long been the standard for evaluating treatment response in brain tumors. The latest update, RANO 2.0, incorporates new guidelines to address challenges associated with modern therapies, such as immunotherapy and targeted treatments. ...
Trust our experienced Visual Function specialists to provide customizable services to keep your study timelines on track....
Equipment certification plays a crucial role in maintaining and improving image quality in clinical trials. Learn how it impacts the overall quality of imaging in our info sheet....
Deciding it’s time to engage a new clinical endpoint service provider is never easy, but sometimes it’s necessary. Your current provider may not have the experience or scalability you need to move your programs ahead....
Endothelial Cell Count (ECC) is an important measurement to evaluate corneal endothelial cell health. MERIT provides masked, independent ECC reading, as required in many ocular clinical trials....
Not all technology platforms are created equal. MERIT’s EXCELSIOR™ system not only increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools, but it also provides the regulatory assurance of FDA 510(k) clearance. Learn what benefits FDA 510(k) clearance offers in our...
MERIT’s ISO 13485 certification of our Quality Management System provides more than just regulatory compliance. It demonstrates our commitment to quality, safety, efficiency, and consistency. Read our info sheet to learn the advantages of collaborating with an ISO 13485 certified company like MERIT....
MERIT’s cloud-based EXCELSIOR software platform enables easy upload of oncology images (CT, MRI, PET) to one secure, validated and FDA-cleared application. This facilitates real-time, trackable, and transparent communication. Learn more in our info sheet....
MERIT is a global clinical trial endpoint services provider offering reliable and attentive expertise in our therapeutic areas. Learn more about what sets MERIT apart in this info sheet....
Gene therapy trials in Inherited Retinal Diseases (IRDs) present unique challenges for biopharma drug developers. Choosing MERIT as your clinical endpoint expert gives you access to solutions based on experience supporting 31 gene therapy trials in IRDs....
What if your company’s early meetings with the FDA to review your preclinical data have indicated a need for ophthalmology safety endpoints in your upcoming non-ophthalmology clinical trial? Discover what your next steps should be in this info sheet....